v3.25.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Series G Convertible Preferred Shares [Member]
Additional Paid-In Capital
Accumulated other comprehensive loss
Accumulated Deficit
Class A Common Stock
Balance, shares at Jun. 30, 2023           37,344,739
Balance, amount at Jun. 30, 2023 $ 35,952,525 $ 0 $ 242,808,771 $ 606,536 $ (207,836,229) $ 373,447
Employee Stock Purchase Plan, shares           30,447
Employee Stock Purchase Plan, amount $ 39,677 0 39,373 0 0 $ 304
Exercise of stock options, RSUs & RSAs, net, shares 3,000         945,188
Exercise of stock options, RSUs & RSAs, net, amount $ 0 0 (9,452) 0 0 $ 9,452
Issuance of common stock under public equity placement, shares           585,483
Issuance of common stock under public equity placement, amount 806,332 0 800,477 0 0 $ 5,855
Issuance of common stock for acquisition of Visimid, shares           348,786
Issuance of common stock for acquisition of Visimid, amount 486,054 0 482,566 0 0 $ 3,488
Stock-based compensation on stock options, RSUs & RSAs 1,019,023 0 1,019,023 0 0 0
Foreign currency translation adjustment (96,600) 0 0 (96,600) 0 0
Net loss (8,007,346) 0 0 0 (8,007,346) $ 0
Balance, shares at Jun. 30, 2024           39,254,643
Balance, amount at Jun. 30, 2024 30,199,665 0 245,140,758 509,936 (215,843,575) $ 392,546
Employee Stock Purchase Plan, shares           9,369
Employee Stock Purchase Plan, amount $ 14,385 0 14,292 0 0 $ 93
Exercise of stock options, RSUs & RSAs, net, shares 133,078         593,791
Exercise of stock options, RSUs & RSAs, net, amount $ 3,175 0 (2,763) 0 0 $ 5,938
Issuance of common stock for acquisition of Visimid, shares           382,253
Issuance of common stock for acquisition of Visimid, amount 713,946 0 710,123 0 0 $ 3,823
Stock-based compensation on stock options, RSUs & RSAs 953,795 0 953,795 0 0 0
Foreign currency translation adjustment 468,750 0 0 468,750 0 0
Net loss (14,873,182) $ 0 0 0 (14,873,182) 0
Issuance of preferred stock under private equity placement, net of fees, shares   24,956        
Issuance of preferred stock under private equity placement, net of fees, amount 0 $ 19,481,376 0 0 0 $ 0
Shares issued as compensation, shares           49,000
Shares issued as compensation, amount 89,670 0 89,180 0 0 $ 490
Issuance of common stock for acquisition of G5, shares           1,972,501
Issuance of common stock for acquisition of G5, amount 4,872,068 0 4,852,343 0 0 $ 19,725
Issuance of common stock under private equity placement, net of fees, shares           687,750
Issuance of common stock under private equity placement, net of fees, amount 1,590,892 0 1,584,014 0 0 $ 6,878
Issuance of warrants under private equity placement, net of fees 177,445 0 177,445 0 0 0
Preferred cumulative dividends plus accretion (14,751,134) 14,751,134 (14,751,134) 0 0 0
Reclassification of warrant liability 6,185,293 $ 0 6,185,293 0 0 $ 0
Balance, shares at Jun. 30, 2025   24,956       42,949,307
Balance, amount at Jun. 30, 2025 $ 15,644,768 $ 34,232,510 $ 244,953,346 $ 978,686 $ (230,716,757) $ 429,493